Congenital adrenal hyperplasia. Molecular characterization

Area of Science:

• Genetics
• Endocrinology
• Molecular Biology

Background:

• Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting the adrenal glands.
• Molecular defects in the 21-hydroxylase gene (CYP21) are the primary cause of CAH.
• Understanding these defects is crucial for diagnosis and management.

Purpose of the Study:

• To investigate the spectrum of molecular defects in the CYP21 gene in Chinese patients with CAH.
• To correlate identified mutations with clinical phenotypes (salt-wasting, simple virilizing, nonclassical).

Main Methods:

• Recruitment of 20 Chinese CAH patients (8 SW, 11 SV, 1 NC).
• Utilized two rounds of polymerase chain reaction (PCR) to amplify CYP21 gene fragments.
• Employed amplification-created restriction site (ACRS) analysis and direct DNA sequencing to identify mutations.

Main Results:

• Identified 10 distinct mutations in the CYP21 gene, including 9 point mutations and gene deletions/conversions.
• The most frequent mutations were CD172 (I172N), IVS-II 656, and gross gene deletion/conversion.
• Salt-wasting (SW) patients exhibited severe mutations, while simple virilizing (SV) patients often carried the CD172 (I172N) mutation.

Conclusions:

• The study identified 10 novel mutations contributing to CAH in the Chinese population.
• Genotype-phenotype correlations align with existing literature.
• PCR and ACRS analysis are valuable tools for genetic counseling and prenatal diagnosis in families at risk for CAH.